Poll: Supreme Court Favors Roche in HIV Patent Dispute: Do You Agree?

Article

The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus.

The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus. While there, he signed a contract assigning any inventions arising from his time there to Cetus; he signed a similar agreement with Stanford. Roche acquired Cetus’s rights to the test and developed and commercialized a widely used kit; Stanford sued for patent infringement.

Stanford argued that Dr Holodniy could not assign rights to Cetus due to the Bayh-Dole Act, which deals with intellectual property arising from federally funded research.

Vote in the poll and share your comments with colleagues below.

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.